Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other
companies in this sector in Taiwan:
Pharmally International Holding Company Ltd
sales of 5.18 billion Taiwanese Dollars [US$170.17 million]
of which 35%
was Glass Bottle),
Standard Chem. & Pharm. Co Ltd
(3.57 billion Taiwanese Dollars [US$117.45 million]
of which 58%
was Pharmaceuticals), and
Formosa Laboratories, Inc
(2.69 billion Taiwanese Dollars [US$88.35 million]
of which 100%
was Active Pharmaceutical Ingredient).
Tty Biopharm Company Limited reported sales of 4.04 billion Taiwanese Dollars (US$132.67 million)
December of 2018.
decrease of 1.0%
versus 2017, when the company's sales were 4.08 billion Taiwanese Dollars.
Contributing to the drop in overall sales was the 11.9% decline
in Anti-Infection Drug, from 803.70 million Taiwanese Dollars to 707.69 million Taiwanese Dollars.
However, these declines were partially offset by the increase in sales of
Anti-Cancer Drug (up 2.9% to 2.56 billion Taiwanese Dollars)
Cardiovascular and Gastrointestinal Drug (up 6.0% to 515.65 million Taiwanese Dollars)
Taipei Branch (up 5.0% to 234.89 million Taiwanese Dollars)
Other (up 58.4% to 20.03 million Taiwanese Dollars)